UPSpace will be temporarily unavailable tonight from 19:00 to 23:00 (South African Time) due to scheduled maintenance. We apologise for any inconvenience this may cause and appreciate your understanding
 

Molecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemase-producing isolates of Klebsiella pneumoniae in South Africa

dc.contributor.authorJacobson, Rachael
dc.contributor.authorManesen, M.R.
dc.contributor.authorMoodley, C.
dc.contributor.authorSmith, M.
dc.contributor.authorWilliams, S.G.
dc.contributor.authorNicol, M.P.
dc.contributor.authorBamford, Colleen
dc.date.accessioned2016-02-19T05:28:56Z
dc.date.available2016-02-19T05:28:56Z
dc.date.issued2015-12
dc.description.abstractBACKGROUND : Klebsiella pneumoniae is an opportunistic pathogen often associated with nosocomial infections. A suspected outbreak of K. pneumoniae isolates, exhibiting reduced susceptibility to carbapenem antibiotics, was detected during the month of May 2012 among patients admitted to a haematology unit of a tertiary academic hospital in Cape Town, South Africa (SA). OBJECTIVES : An investigation was done to determine possible epidemiological links between the case patients and to describe the mechanisms of carbapenem resistance of these bacterial isolates. Methods. Relevant demographic, clinical and laboratory information was extracted from hospital records and an observational review of infection prevention and control practices in the affected unit was performed. Antimicrobial susceptibility testing including phenotypic testing and genotypic detection of the most commonly described carbapenemase genes was done. The phylogenetic relationship of all isolates containing the blaOXA-181 carbapenemase gene was determined by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing. Results. Polymerase chain reaction analysis identified a total of seven blaOXA-181-positive, carbapenem-resistant K. pneumoniae isolates obtained from seven patients, all from a single unit. These isolates were indistinguishable using PFGE analysis and belonged to sequence type ST-14. No other carbapenemase enzymes were detected. CONCLUSION : This is the first documented laboratory-confirmed outbreak of OXA-181-producing K. pneumoniae in SA, and highlights the importance of enforcing strict adherence to infection control procedures and the need for ongoing surveillance of antibiotic-resistant pathogens in local hospitals.en_ZA
dc.description.librarianhb2015en_ZA
dc.description.sponsorshipGlobal Disease and Detection Funding, Centre for Opportunistic Tropical and Hospital Infections,National Institute for Communicable Diseases and the National Health Laboratory Service, Johannesburg.en_ZA
dc.description.urihttp://www.sama.co.zaen_ZA
dc.identifier.citationJacobson, RK, Manesen, MR, Moodley, C, Smith, M, Williams,SG, Nicol, MP & Bamford, CM 2015, 'Molecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemase-producing isolates of Klebsiella pneumoniae in South Africa', South African Medical Journal, vol. 105, no. 12, pp. 1030-1035.en_ZA
dc.identifier.issn0256-9574 (print)
dc.identifier.issn2078-5135 (online)
dc.identifier.other10.7196/SAMJ.2015.v105i12.9926
dc.identifier.urihttp://hdl.handle.net/2263/51465
dc.language.isoenen_ZA
dc.publisherSouth African Medical Associationen_ZA
dc.rightsSouth African Medical Associationen_ZA
dc.subjectKlebsiella pneumoniaeen_ZA
dc.subjectSouth Africa (SA)en_ZA
dc.subjectAntibiotic-resistant pathogensen_ZA
dc.subjectOutbreaken_ZA
dc.subjectCarbapenem resistanten_ZA
dc.titleMolecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemase-producing isolates of Klebsiella pneumoniae in South Africaen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Jacobson_Molecular_2015.pdf
Size:
249.1 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: